Letizia C, Mazzaferro S, Morabito S, De Ciocchis A, Cerci S, D'Ambrosio C, Cinotti G A, Scavo D
Cattedra di Nefrologia, Università di Roma La Sapienza, Italy.
Int Urol Nephrol. 1995;27(4):465-70. doi: 10.1007/BF02550085.
The aim of this study was to examine serum angiotensin converting enzyme (SACE) activity and the renin-angiotensin-aldosterone system in patients on chronic haemodialysis during one routine dialysis session. Fourteen patients (8 men and 6 women; mean age 51.9 +/- 17 years) with end stage renal disease, receiving regular haemodialysis treatment for an average of 6 months, were studied. The patients were dialysed for 4 hours three times a week using cellulose membranes (cuprophan). After an overnight fast blood samples were taken from the patients before and after the haemodialysis session. Serum and plasma were separated and stored at -20 degrees C until assayed for SACE, plasma renin activity (PRA) and plasma aldosterone (PA). For comparison, SACE, PRA and PA were also measured in 8 patients after renal allotransplantation and on treatment with cyclosporin A (5 men, 3 women; mean age 38.9 +/- 12.3 years) and in 19 healthy subjects (13 men, 6 women; mean age 38.9 +/- 12.3 years). SACE levels in patients with chronic renal failure and on haemodialysis (17.55 +/- 9.03 nmol/ml/min) and in patients with renal transplantation (18.12 +/- 3.92) were significantly higher than those of the healthy subjects (9.27 +/- 1.67) (p < 0.0001, respectively). At the end of the dialysis session SACE levels in patients with chronic renal failure (14.9 +/- 7.19) did not increase in respect to pre-dialysis levels (17.55 +/- 9.03; p = 0.132). PRA and PA values increased after the dialysis session (p < 0.026 and p < 0.044, respectively). Correlation of SACE with PRA and PA was not demonstrated before or after the dialysis session. In patients with chronic renal failure and on haemodialysis our findings suggest that a disarrangement exists between the circulatory components of the reninangiotensin-aldosterone system before and after the dialysis session.
本研究旨在检测慢性血液透析患者在一次常规透析过程中血清血管紧张素转换酶(SACE)活性及肾素 - 血管紧张素 - 醛固酮系统。对14例终末期肾病患者(8例男性,6例女性;平均年龄51.9±17岁)进行了研究,这些患者接受规律血液透析治疗平均6个月。患者使用纤维素膜(铜仿膜)每周透析3次,每次4小时。透析前一晚禁食后,在血液透析前后采集患者血样。分离血清和血浆并储存于 -20℃,直至检测SACE、血浆肾素活性(PRA)和血浆醛固酮(PA)。作为对照,还对8例肾移植后接受环孢素A治疗的患者(5例男性,3例女性;平均年龄38.9±12.3岁)和19名健康受试者(13例男性,6例女性;平均年龄38.9±12.3岁)检测了SACE、PRA和PA。慢性肾衰竭并接受血液透析患者的SACE水平(17.55±9.03 nmol/ml/min)及肾移植患者的SACE水平(18.12±3.92)均显著高于健康受试者(9.27±1.67)(p均<0.0001)。在透析结束时,慢性肾衰竭患者的SACE水平(14.9±7.19)相对于透析前水平(17.55±9.03;p = 0.132)未升高。透析后PRA和PA值升高(分别为p < 0.026和p < 0.044)。透析前后均未显示SACE与PRA和PA之间存在相关性。对于慢性肾衰竭并接受血液透析的患者,我们的研究结果表明,透析前后肾素 - 血管紧张素 - 醛固酮系统的循环成分之间存在紊乱。